शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MEDICOBSEMedico Remedies Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 3 Apr, 2025 · 15:32 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Haresh Kapurlal Mehta

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.3%Reaction day
₹55.00
prior close
₹54.90
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-3.6%+5.9% vs market
Pharmaceuticals peers, median of 150sector-2.8%+5.1% vs sector

On the reaction day the stock moved 5.9 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.5
10m
+1.3
15m
+1.8
30m
+1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.3-3.6+5.9-2.8+5.1
Next day
+3.6-7.8+11.4-7.1+10.7
2d
+4.5-5.6+10.1-5.3+9.8
3d
+3.6-6.8+10.4-6.6+10.2
4d
+8.1-3.6+11.7-4.2+12.3
5d
+6.6-0.5+7.1-1.7+8.3
1w
+2.7+1.1+1.7-1.1+3.8
15d
+1.0-1.2+2.2-1.8+2.8
1m
-1.8+0.2-2.0-1.6-0.2
2m
-5.5+11.1-16.6+4.3-9.8
3m
-23.0+14.5-37.5+4.9-27.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Haresh Kapurlal Mehta, a promoter of Medico Remedies Ltd, sold 1,00,000 equity shares (0.12% of total share capital) through an open market transaction on 28 March 2025. As a result, his shareholding in the company declined from 1,72,29,200 shares (20.76%) to 1,71,29,200 shares (20.64%). The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations. The total equity share capital of the company remains at 8,29,84,000 shares of Rs. 2 each, worth Rs. 16.59 crore. The sale is small in size and the promoter's overall stake remains comfortable at over 20%.

Likely market impact

This is a minor promoter sell-off (only 0.12% of equity) and is unlikely to meaningfully affect the stock price or signal any major concern. The promoter continues to hold a significant 20.64% stake, so long-term confidence in the company remains largely intact.